Breaking News
January 20, 2018 - Evidensia Sweden orders Sectra cloud-based PACS for reviewing all medical images
January 20, 2018 - Researchers test new anti-malaria medication
January 20, 2018 - Small Joint Surgeries Drop among RA Patients
January 20, 2018 - Young people with shared residency have fewer mental problems
January 20, 2018 - Childhood physical activity may have far-reaching implications
January 20, 2018 - Overweight female kidney donors of childbearing age may have greater preeclampsia risk
January 20, 2018 - MSU scientists seek to identify brain mechanisms related to psychosis
January 20, 2018 - Syndax Pharmaceuticals Announces Clinical Collaboration to Evaluate Entinostat in Combination with anti-PD-L1 Cancer Immunotherapy in Breast Cancer
January 20, 2018 - Endoscopes Over Microscopes in Retinal Surgery: Ophthalmology Times
January 20, 2018 - Technology not taking over children’s lives despite screen-time increase
January 20, 2018 - Study finds extensive contamination around lead battery recycling plants in 7 African countries
January 20, 2018 - Flu may pass to others through exhaled breath, study shows
January 20, 2018 - Neuronal loss very limited in Alzheimer’s disease, new study shows
January 20, 2018 - Novel robot can aid treatment of rare birth defect
January 19, 2018 - TherapeuticsMD Announces Submission of New Drug Application for TX-001HR
January 19, 2018 - Fighting Infant Mortality | Medpage Today
January 19, 2018 - Researchers offer new evidence on four-year-old children’s knowledge about ecology
January 19, 2018 - Analysis finds overlooked crucial factor in determining prognosis for DIPGs
January 19, 2018 - Review explores consequences of genetic testing and cancer risk-reducing surgery
January 19, 2018 - Morning Break: HHS Div. of Religious Freedom; Trump’s Heart Health; Minister of Loneliness
January 19, 2018 - Parkinson’s disease ‘jerking’ side effect detected by algorithm
January 19, 2018 - New analysis finds dramatic increases in maternal mortality rates
January 19, 2018 - Study reveals key mechanism of how cancer metastasis happens
January 19, 2018 - Weight-Loss Surgery’s Benefits Wane Over Time for Diabetics
January 19, 2018 - Cath Lab Recap: Sapien 3 Delivery System Recall; Transatlantic PCI Smackdown
January 19, 2018 - Parkinson’s treatment could be more effective, student finds
January 19, 2018 - New vaccine approach offers effective protection against tuberculosis
January 19, 2018 - Home care agencies often wrongly deny Medicare help to the chronically ill
January 19, 2018 - One hundred percent fruit juice does not alter blood sugar levels
January 19, 2018 - Prebiotics could enhance learning and memory skills in infants
January 19, 2018 - CMS May Cover MRI With Cardiac Devices Across the Board
January 19, 2018 - As income rises, women get slimmer—but not men
January 19, 2018 - Researchers develop adhesive materials to prevent bracket stains on teeth
January 19, 2018 - Flu can be spread without coughs and sneezes
January 19, 2018 - AMSBIO’s new recombinant protein shows great promise for organoid culture
January 19, 2018 - AbbVie’s Upadacitinib Granted Breakthrough Therapy Designation from the U.S. Food and Drug Administration for Atopic Dermatitis
January 19, 2018 - ASH: Pomalidomide Dose Escalation Improves Response
January 19, 2018 - Is your child’s school an obesity risk?
January 19, 2018 - Scientists describe groundbreaking training effect on the innate immune system
January 19, 2018 - MAST announces new AmpC, ESBL & Carbapenemase Detection Set
January 19, 2018 - Signaling molecules likely involved in concussions, rodent studies show
January 19, 2018 - Mast introduces Carba plus for CPE and OXA-48 confirmation
January 19, 2018 - Paleolithic diet helps overweight women maintain weight loss
January 19, 2018 - Agios Submits New Drug Application to the FDA for Ivosidenib for the Treatment of Patients with Relapsed/Refractory AML and an IDH1 Mutation
January 19, 2018 - This Flu Season, Don’t Forget About Tamiflu
January 19, 2018 - Amsterdam wins battle to host EU medicines agency after Brexit
January 19, 2018 - Study suggests movement as accurate method to diagnose neurodevelopmental disorders
January 19, 2018 - Maximize resolution in deep imaging for neuroscience research with Olympus TruResolution objectives
January 19, 2018 - Bilingualism may benefit children with ASD
January 19, 2018 - FDA Alert: Levofloxacin in 5 Percent Dextrose 250mg/50mL by AuroMedics: Recall
January 19, 2018 - USPSTF Not Backing Ankle-Brachial Index, CRP, or Coronary Calcium
January 19, 2018 - Higher omega-3 fatty acid intake tied to lower glaucoma risk
January 19, 2018 - Findings reveal conventional cancer therapy as double-edged sword
January 19, 2018 - Health Highlights: Jan. 16, 2018
January 19, 2018 - Morning Break: Anti-Emetic Warning; Uninsured Rate Jumps; Flu Worsens Saline Shortage
January 19, 2018 - Increased use of ambulatory surgery centers for cataract surgery
January 19, 2018 - Not-for-profit hospitals coming up with their own generic medicines to combat shortages
January 19, 2018 - $500 cancer detection blood tests may soon become reality
January 19, 2018 - Chronic traumatic encephalopathy may start early even without signs of concussions
January 19, 2018 - Warm-up program for children cuts soccer injuries by 50%
January 19, 2018 - ‘You’re Old and You Need Tests’: What We Heard This Week
January 19, 2018 - Egg-preserving hysterectomy raises heart risks later: study
January 19, 2018 - GA-map Dysbiosis Test identifies IBS patients who respond to FODMAP diet, study shows
January 19, 2018 - Study explores mortality and health-related habits in former elite athletes and their brothers
January 19, 2018 - New biodegradable sensors could assist doctors
January 19, 2018 - Modular gene enhancers may be suitable target in treatment of blood cancer
January 18, 2018 - New precision medicine trial for metastatic pancreatic cancer
January 18, 2018 - Shire Receives FDA Breakthrough Therapy Designation for Maribavir, an Investigational Treatment for Cytomegalovirus (CMV) Infection in Transplant Patients
January 18, 2018 - Pre-Existing Patient-Valve Mismatch Trips Up ViV Implant
January 18, 2018 - Adolescents: health risks and solutions
January 18, 2018 - US woman delivers baby from embryo frozen for 24 years
January 18, 2018 - Study identifies new target for treatment of depression
January 18, 2018 - LJI study reveals key player that promotes skin inflammation in atopic dermatitis
January 18, 2018 - Study devises efficient and economical strategy to screen breast and ovarian cancer gene mutations
January 18, 2018 - Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla (AG200-15) for the Prevention of Pregnancy
January 18, 2018 - Gene Therapy for Inherited Retinal Dystrophy Gets FDA Clearance
January 18, 2018 - Researchers identify a new chemical pathway that helps the brain detect sweet, savory and bitter flavors
January 18, 2018 - IBV develops platform that helps companies to diagnose wellbeing of their workforce
January 18, 2018 - Study to test new precision medicine approach for metastatic pancreatic cancer
January 18, 2018 - World’s first vaccine relieves grass pollen allergy symptoms by at least 25%, study shows
Gene enhancing method is helping discover attainable new drug goals for KRAS-driven cancers

Gene enhancing method is helping discover attainable new drug goals for KRAS-driven cancers

image_pdfDownload PDFimage_print

Cancers pushed by means of mutations within the KRAS gene are a few of the most threatening. For many years, researchers have attempted unsuccessfully to without delay goal mutant KRAS proteins as a method to regard tumors. As an alternative of focused on mutant KRAS itself, researchers at College of California San Diego College of Drugs are actually in search of different genes or molecules that, when inhibited, kill most cancers cells best when KRAS could also be mutated.

The workforce used the CRISPR-Cas9 gene enhancing method to systematically inactivate each gene within the genome of human colorectal most cancers cells with and with out mutant KRAS. They discovered that expansion of KRAS-mutant colorectal most cancers cells in mice used to be lowered by means of roughly 50 % when two genes that encode metabolic enzymes — NADK and KHK — have been additionally inactivated.

The learn about, revealed September 27 in Most cancers Analysis, supplies attainable new drug goals for KRAS-driven cancers.

“We didn’t get those identical effects with most cancers cells grown within the lab — the expansion inhibition we noticed when the NADK and KHK genes have been inactivated best happens in tumors in a mammalian gadget, in a extra real looking microenvironment the place the tumor has to live to tell the tale,” mentioned senior writer Tariq Rana, PhD, professor of pediatrics at UC San Diego College of Drugs and Moores Most cancers Heart. “That means that the metabolic dependencies of tumor cells rising in a laboratory dish might fluctuate dramatically in comparison to the similar cells rising in a dwelling gadget, underscoring attainable boundaries of usual laboratory-based most cancers mobile expansion exams.”

Roughly 20 to 30 % of all human cancers have mutations within the KRAS gene. KRAS mutations happen in most of the maximum deadly and maximum tough to regard cancers, together with lung, pancreatic and colorectal most cancers. KRAS mutant most cancers cells are ready to rewire their metabolism in some way that provides them a expansion benefit in comparison to customary cells.

Rana’s option to treating KRAS-driven cancers — inhibiting different genes or molecules along with KRAS — is named “artificial lethality” since the intervention is best deadly to the mutated cells. In a prior learn about, Rana’s workforce used a library of microRNAs, small items of genetic subject matter, to systematically block protein manufacturing and search for the ones inhibitions which can be artificial deadly together with KRAS mutations.

Of their newest learn about, Rana’s workforce used CRISPR-Cas9 to systematically inactivate genes in two human colorectal most cancers mobile traces — one with customary KRAS and one with a mutant KRAS. They then examined the power of each and every of those mobile traces to develop as tumors in mice. They discovered that inactivating two metabolic enzymes, NADK and KHK, lowered the expansion of KRAS-mutant tumors by means of roughly 50 %, however had no impact on customary KRAS tumors. Additionally they blocked those identical enzymes with commercially to be had small molecule inhibitors and noticed vital relief in tumor expansion in mice best in tumor cells with mutant KRAS.

Rana and workforce additionally known a number of new genes that, when inactivated, had the other impact — they higher KRAS-mutant tumor expansion, however now not the expansion of ordinary KRAS tumors. All these genes are referred to as “tumor suppressors” as a result of they typically stay most cancers mobile expansion in test.

“Some of the sudden findings from our learn about is how acting this sort of genetic display screen without delay in a mammalian microenvironment published now not best new artificial deadly interactions, but additionally new tumor suppressor genes which can be depending on KRAS mutations,” mentioned first writer Edwin Yau, MD, PhD, a hematology/oncology and Most cancers Therapeutics Coaching Program fellow in Rana’s lab.

The sort of new tumor suppressor genes encodes INO80C, a big multi-subunit protein that, amongst different issues, stabilizes the genome. Rana, Yau and co-workers are actually taking steps to hold their findings ahead, with without equal objective of higher working out how KRAS-mutant cancers expand and translating those insights into creating new remedies to prevent them.



Tagged with:

About author

Related Articles